i-SENS, Inc. (KOSDAQ:099190)
15,010
-30 (-0.20%)
At close: Jan 19, 2026
i-SENS Market Cap
i-SENS has a market cap or net worth of 414.38 billion as of January 16, 2026. Its market cap has decreased by -9.46% in one year.
Market Cap
414.38B
Enterprise Value
519.58B
Revenue
313.10B
Ranking
n/a
PE Ratio
598.62
Stock Price
15,010.00
Market Cap Chart
Since January 30, 2013, i-SENS's market cap has increased from 232.76B to 414.38B, an increase of 78.03%. That is a compound annual growth rate of 4.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 415.21B | -5.41% |
| Dec 30, 2025 | 438.95B | 4.01% |
| Dec 30, 2024 | 422.03B | -46.36% |
| Dec 28, 2023 | 786.74B | 74.15% |
| Dec 29, 2022 | 451.77B | 9.85% |
| Dec 30, 2021 | 411.25B | 0.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |